Rating agency notes market leadership in hospital professional liability and strong financials

BETA Healthcare Group once again received solid reviews of its financial strength and overall credit rating from AM Best, the insurance industry’s leading credit rating agency. BETA Healthcare Group is rated “A” (Excellent) by AM Best with a stable outlook. This rating reflects BETA’s balance sheet strength, which AM Best categorizes as “Strongest.” Some key aspects of AM Best’s rating rationale include:

“BETA’s sole focus on healthcare and commitment to patient and employee safety positions us as a unique partner to the healthcare industry.” – Corey Grove, CEO BETA Healthcare Group

Health Technology Insights: Eleanor Health Joins Cigna and Evernorth Networks

  • Strongest level of risk-adjusted capitalization as measured by Best’s Capital Adequacy Ratio (BCAR)
  • Prudent loss reserving practices, resulting in consistently favorable development of prior accident year reserves
  • Sound liquidity measures supported by an invested asset base that predominantly consists of high-quality fixed-income securities
  • Overall results have been consistently profitable over the most recent five-year period

Health Technology Insights: Halozyme to Acquire Elektrofi for Drug Delivery Expansion

BETA is recognized as a leading provider of hospital professional liability and the second-largest medical professional liability (MPL) provider in California, based on 2024 direct premium written (DPW), and for having a unique joint powers structure that allows for broader coverage and responsive rates.

“Our financial strength and broad footprint on the West Coast allow us to provide high-quality services to our geographically diverse customers,” said Corey Grove, CEO of BETA Healthcare Group. “BETA’s sole focus on healthcare and commitment to patient and employee safety positions us as a unique partner to the healthcare industry. We are nimble and leverage our expertise to create innovative and leading-edge risk management solutions that assist healthcare organizations to deliver quality care, positive patient experiences, and a safe workplace environment where employees can thrive.”

Health Technology Insights: Biocon Sets U.S. Launch Date for Denosumab Biosimilars

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire